Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

NCT05919797 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Obesity

Interventions

DRUG: Naltrexone-Bupropion Combination

Sponsor

Columbia University

Collaborators

[object Object]